During the last decades, heart failure (HF) has developed a major burden in whole world, increasingly affecting millions.
The 3.6 million people are newly diagnosed every year only in Europe and its prevalence isgoing up to 3.5% (increasing 30-40%) within next 10 years. HF is has recently been classified into three subtypes, namely HF with reduced ejection fraction (HFrEF), HF with preserved ejection fraction (HFpEF) and HF mid-range ejection fraction (HFmrEF) and it is known the prevalence, incidence, mortality and morbidity rates show geographic variations, depending on the different etiologies and clinical characteristics among patients with heart failure. Therefore, we would like also to invite you to take part of our scientific programme by presenting your national epidemiologic data or national strategies on the prevention, diagnosis or treatment of HF. Organizing committee will cover presenter’s registration fee, but travel expenses and hotel accommodation will not be covered by the congress.